Using this mouse in the context of pancreatic cancer, we reveal significant biological insights into the in situ regulation of E-cadherin during normal tissue homeostasis, disease initiation, and progression of pancreatic cancer while highlighting its potential utility for monitoring drug target activity in vivo using FRAP. This evidence concerns the gene CDH1 and pancreatic neoplasm.